Core values: Fitness market continues to innovate despite stock market correction
Share price woes mask underlying strong revenue growth for home fitness brands with subscription numbers outpacing pre-pandemic expectations.
31 May 2022
Despite high-profile share price collapses the top eight home fitness stocks have witnessed strong revenue growth over the past two years (17% CAGR), attracting the attention of entrepreneurs and investors looking to capitalise on changing consumer attitudes to health and wellness.
Sector leaders such as Peloton, Lululemon and Garmin have collectively seen close to $90B wiped off their peak pandemic valuation but have successfully established recurring revenue streams through subscriptions. Peloton’s revenue has increased from $1.2B in 2019 to $4.1B in 2021 with two thirds of that income attributed to monthly access to its platform. Similarly, in September 2020 virtual cycling community Zwift achieved ‘Unicorn’ status with a $450M Series C funding round. As pandemic restrictions are relaxed these changes in consumer behaviour largely remain. Connected fitness, digital health communities and health and nutrition coaching start ups therefore continue to drive change in this market.
Customers can read the full analyst note on-platform. Not a customer yet? Request a demo of HolonIQ’s market intelligence platform.
Where is this data coming from?
Related Research
Global Health Funding 2022 – Half Year Update
1 July 2022.Funding continues to flow in the first half of 2022 with $49.7B growth capital for health firms, despite a correction for digital and concerns around falling valuations.
The Complete List of Global Impact Unicorns
21 June 2022.The Complete List of Global Impact Unicorns
Core values: Fitness market continues to innovate despite stock market correction
31 May 2022.Share price woes mask underlying strong revenue growth for home fitness brands with subscription numbers outpacing pre-pandemic expectations.
Healthcare Megarounds: 2022 activity dominated by Biotech
21 May 2022.66 healthcare funding rounds in excess of $100M, totalling $11.7B in ‘megarounds’ despite a rapidly cooling market
